Biom'Up
Biom'Up is a French specialty medical device company founded in 2005 that designs and manufactures resorbable collagen-based hemostatic products for surgical bleeding control and postpartum hemorrhage applications. The firm has been delisted and currently lacks an active corporate web presence.
- Company typePrivate
- Founded2005
- HeadquartersSaint-priest-ligoure, France
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Biom'Up firmographics
Firmographics- Name
- Biom'Up
- Website
- https://biomup.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Biom'Up is a French specialty medical device company founded in 2005 that designs and manufactures resorbable collagen-based hemostatic products for surgical bleeding control and postpartum hemorrhage applications. The firm has been delisted and currently lacks an active corporate web presence.
- Ownership category
- akta.pro rank
Biom'Up industry classification
Industry- Product category
- Surgical Hemostats
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates) (IMAEAOAL)
Keywords
Where Biom'Up is headquartered
LocationHeadquarters
- HQ city
- Saint-priest-ligoure
- HQ country
- France
- HQ region
- Europe
Markets served
Biom'Up business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Biom'Up product offering
Product offeringCore offering
Biom'Up is a French medical device manufacturer that develops and produces re-absorbable surgical devices based on proprietary collagen technology. The company's core focus is on biodegradable hemostatic products designed for surgical bleeding control and postpartum hemorrhage management, operating within the broader biomaterials and surgical hemostat market.
Differentiator
Problem solved
Functional benefit
Companies that use Biom'Up
Customer profileIdeal customer profiles1 record
Biom'Up technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biom'Up partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medtrade Products Ltdnot specifiedIn March 2023, UK-based Medtrade Products Ltd partnered with Swiss company Laubscher and Co AG to introduce CELOX PPH uterine haemostatic tamponade solution for addressing postpartum hemorrhage in Switzerland. This represents activity in the broader hemostat market that Biom'Up participates in.
Scale indicators1 record
Biom'Up competitors and assessment
Company assessmentDirect peers
- CryoLife: CryoLife (now part of Artivion) develops surgical sealants and hemostats used in cardiac and vascular surgery. Its BioGlue and related surgical adhesive/hemostatic products compete directly with Biom'Up's absorbable hemostatic devices in operating-room settings.
- Baxter International: Baxter is a leading manufacturer of surgical hemostats and sealants, most notably FLOSEAL (a gelatin matrix hemostatic sealant) and TISSEEL (fibrin sealant). Its gelatin-based FLOSEAL is highly comparable to Biom'Up's collagen-based absorbable hemostats in indication and surgical setting.
- Medtrade Products: Medtrade Products makes CELOX hemostatic gauze and the CELOX PPH uterine tamponade for postpartum hemorrhage. Both companies compete in the biodegradable/absorbable hemostat category, with overlapping indications in surgical and obstetric bleeding control.
- Ethicon (Johnson & Johnson): Ethicon is a market-leading surgical hemostat and sealant franchise (SURGIFLO Hemostatic Matrix, EVICEL Fibrin Sealant). Its absorbable, flowable hemostatic matrix products directly compete with Biom'Up's collagen-based offering in the same surgical bleeding-control category.
Broad incumbents
- Integra LifeSciences: Integra LifeSciences offers a portfolio of hemostatic agents, dural repair, and surgical products, including collagen-based absorbable hemostats. It serves as a broader incumbent competing in the same surgical hemostasis and tissue management space.
- Becton Dickinson (BD): BD is a diversified medical device incumbent with a portfolio that includes hemostatic products and surgical adjuncts. Its scale, regulatory resources, and global commercial reach make it a key competitive force in surgical hemostasis alongside Biom'Up's niche offerings.
Emerging players
- Marine Polymer Technologies: Marine Polymer Technologies develops poly-N-acetyl glucosamine (pGlcNAc)-based hemostatic devices (SyvekPatch, Rapid Deployment Hemostat). As a smaller specialist with biomaterial-based hemostats, it is comparable to Biom'Up in scale and technology approach.
- Z-Medica (QuikClot): Z-Medica, now part of Teleflex, markets QuikClot hemostatic gauze and kaolin-based hemostatic agents used in surgical and trauma settings. It competes in the same absorbable/kaolin-based hemostat category with overlapping indications.
- Advanced Medical Solutions: Advanced Medical Solutions develops and commercializes absorbable hemostats, sealants, and tissue adhesives (e.g., LiquiBand, ActivHeal). As a UK-based specialist with comparable size and focus, it is a relevant emerging competitor and potential comparable for Biom'Up.
- CorMatrix Cardiovascular: CorMatrix developed ECM (extracellular matrix) biomaterial-based absorbable implants for cardiac and vascular surgery. Its collagen/ECM-based absorbable technology platform is thematically comparable to Biom'Up's collagen-based re-absorbable medical device approach.
Market position
Customer concentration
Biom'Up social profiles
Digital presenceBiom'Up financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biom'Up leadership team
Management profileNumber of profiles
Profiles5 records
Biom'Up funding detail
Funding detailFunding overview
Funding rounds5 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biom'Up M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biom'Up
What does Biom'Up do?
Biom'Up is a French medical device manufacturer that develops and produces re-absorbable surgical devices based on proprietary collagen technology. The company's core focus is on biodegradable hemostatic products designed for surgical bleeding control and postpartum hemorrhage management, operating within the broader biomaterials and surgical hemostat market.
When was Biom'Up founded?
Biom'Up was founded in 2005. It employs 51 to 100 people.
Where is Biom'Up based?
Biom'Up is headquartered in Saint-priest-ligoure, France, in the Europe region.
Who are Biom'Up's main competitors?
Direct peers on record are CryoLife, Baxter International, Medtrade Products and Ethicon (Johnson & Johnson). Broad incumbents are Integra LifeSciences and Becton Dickinson (BD). Emerging players are Marine Polymer Technologies, Z-Medica (QuikClot), Advanced Medical Solutions and CorMatrix Cardiovascular.
Does Biom'Up have an API?
No public API is recorded for Biom'Up.
What industry is Biom'Up in?
Biom'Up's product category is Surgical Hemostats. Its primary akta.pro industry code is IMAEAOAL, Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates). Its NAICS code is 339113 and its SIC code is 2836.